Skye Bioscience Inc (SKYE)

[cjarmstrong]

There were 45 million shares outstanding on a fully converted basis (including warrants and options) as stated in their latest presentation. Series F raised $2mm at $.15/share, so $13.33mm shares, now Emerald is buying 25 million shares and 25 million warrants from Nemus at $.10, PLUS preferred stock from existing holders.

So there will be ~110 million fully diluted, as well as the shares from the bridge loan.

Do you get it?